Clinical uses of pimozide

Southern Medical Journal

Volumn 86, Issue 3, 1993, Pages 344-349

  Tueth, Michael J ^a   Cheong, Josepha A ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; HALOPERIDOL; PIMOZIDE; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT;

CARDIOVASCULAR DISEASE; DELUSION; DOSE CALCULATION; DRUG EFFECT; DRUG HALF LIFE; DRUG INDICATION; DRUG MECHANISM; DRUG RESISTANCE; ELECTROCARDIOGRAM; EXTRAPYRAMIDAL SYMPTOM; FOOD AND DRUG ADMINISTRATION; GILLES DE LA TOURETTE SYNDROME; HUMAN; MAINTENANCE THERAPY; MENTAL HEALTH CARE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

CLINICAL PROTOCOLS; CLINICAL TRIALS; DELUSIONS; DRUG MONITORING; DRUG RESISTANCE; DRUG UTILIZATION; ELECTROCARDIOGRAPHY; HUMAN; PIMOZIDE; SCHIZOPHRENIA; TOURETTE SYNDROME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0027456656     PISSN: 00384348     EISSN: 15418243     Source Type: Journal    
DOI: 10.1097/00007611-199303000-00019     Document Type: Article

References (35)

1. Munro A, O’Brien JV, Ross D: Two cases of pure or primary erotomania successfully treated with pimozide. Can J Psychiatry 1985; 30:619-622.
2. Sallee FR, Polleck BG, Stiller RL, et al: Pharmacokinetics of pimozide in adults and children with Tourette’s syndrome. J Clin Pharmacol 1987; 27:776-781.
3. Fulop G, Phillips RA, Shapiro AK, et al: ECG changes during haloperidol and pimozide treatment of Tourette’s disorder. Am J Psychiatry 1987; 144:673-675.
4. Feinberg SS, Stanley RK, Eligovich LR, et al: Pimozide treat-ment of the negative schizophrenic syndrome: an open trial. J Clin Psychiatry 1988; 49:235-238.
5. Riding J, Munro A: Pimozide in the treatment of monosymp- tomatic hypochondriacal psychosis. Acta Psychiatr Scand 1975; 52:23-30.
6. American Hospital Formulary Service: AHFS Drug Information. Bethesda, Md, American Society of Hospital Pharmacists, 1991.
7. Chouinard G, Annable L: Pimozide in the treatment of newly admitted schizophrenic patients. Psychopharmacology 1982; 76:13-19.
8. Walter JR, Roth RH: Dopaminergenic neurons: an in vivo sys-tem for measuring drug interactions with presynaptic receptors. Arch Pharmacol 1976; 296:5-14.
9. Gould RJ, Murphy KM, Reynolds IJ: Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists. Proc Natl Acad Sci USA 1983; 80:5122-5125.
10. Shapiro E, Shapiro AK, Fulop G: Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette’s syndrome. Arch Gen Psychiatry 1989; 46:722-730.
11. Carpenter WT Jr, Henrichs DW, Alphus LD: Treatment of negative symptoms. Schizophr Bull 1985; 11:440-452.
12. Arana GW, Hyman SE: Handbook of Psychiatric Drug Therapy. Boston, Little Brown and Co, 2nd Ed, 1991.
13. Hollister LE, Kosek JC: Sudden death during treatment with phenothiazine derivatives. JAMA 1965; 192:1035-1038.
14. Leestma JE, Koenig KL: Sudden death and phenothiazines. Arch Gen Psychiatry 1968; 18:137-148.
15. Alexander CS: Cardiotoxic effects of phenothiazines and related drugs. Circulation 1968; 38:1014-1015.
16. Fowler NO, McCall D, Chou TC: Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs. Am J Cardiol 1976; 37:223-230.
17. Shapiro AK, Shapiro E, Eisenkraft GJ: Treatment of Gilles de la Tourette syndrome with pimozide. Am J Psychiatry 1983; 140:1183-1186.
18. Mesulam MM, Petersen RC: Treatment of Gilles de la Tourette’s syndrome: eight-year, practice-based experience in a predominantly adult population. Neurology 1987; 37:1828-1833.
19. Kolivakis T, Azian H, Kingston E: A double blind comparison of pimozide and chlorpromazine in the maintenance of chronic schizophrenic patients. Cun Ther Res 1974; 16:998-1004.
20. Wilson LG, Roberts RW, Gerber CJ, et al: Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy. J Clin Psychiatry 1982; 43:62-65.
21. Kenway AK, Masheter HC: A double-blind comparison of pimozide (Orap) and chlorpromazine. Clin Trials J 1971; 8(suppl II):39-48.
22. Falloon I, Watt DC, Shepherd M: A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia. Psychol Med 1978; 8:59-70.
23. Anderson K, D’Elian G, Hallberg B, et al: A controlled trial of pimozide and trifluoperazine in chronic schizophrenic syn-dromes. Acta Psychiatr Scand 1974; 249(suppl):43.
24. Piyakulmala S, Corbett L, Ahluwalia Y, et al: High dose pimozide in the treatment of acutely agitated schizophrenia. Cun Ther Res 1977; 22:453-461.
25. Haas S, Beckmann H: Pimozide versus haloperidol in acute schizophrenia, a double-blind controlled study. Pharmacopsychiatry 1982; 15:70-74.
26. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 3rd Ed revised. Washington, DC, APA, 1987.
27. Munro A: Monosymptomatic hypochondriacal psychosis manifesting as delusions of parasitosis, a description of four cases successfully treated with pimozide. Arch Dermatol 1978; 14:940-943.
28. Munro A: Monosymptomatic hypochondriacal psychosis, a diagnostic entity which may respond to pimozide. Can Psychiatr Assoc J 1978; 33:497-500.
29. Munro A, ChmaraJ: Monosymptomatic hypochondriacal psy-chosis: a diagnostic checklist based on 50 cases of the disorder. Can J Psychiatry 1982; 27:374-376.
30. Byrne A, Yatham LN: Pimozide in pathological jealousy. Br J Psychiatry 1989; 155:249-251.
31. Munro A: Pathological jealousy: an excellent response to pimozide. Can Med Assoc J 1984; 131:852-853.
32. Johnson GC, Anton RF: Delusions of parasitosis: differential diagnosis and treatment. South Med J 1985; 78:914-918.
33. Meltzer HY, Sommers AA, Luchins DJ: The effect of neurolep-tics and other psychotropic drugs on negative symptoms in schizophrenia. J Clin Pharmacol 1986; 6:329-338.
34. van Kammen DP, Hommer DW, Malas KL: Effect on positive and negative symptoms in schizophrenia patients: are negative symptoms state dependent? Neuro psychobiology 1987; 18:113-117.
35. Clozaril product information. East Hanover, NJ, Sandoz Pharmaceuticals Corp, January 15, 1991.